Brief: Novonesis Q2 EBIT EUR 192.5 Mln

Novozymes A/S

21/08/2025 07:24

Aug 21 (Reuters) - Novozymes A/S NSISb.CO:

OUTLOOK FY ORGANIC GROWTH 6-8%

9% ORGANIC SALES GROWTH IN H1, FY OUTLOOK NARROWED TO 6-8%

Q2 ADJUSTED EBITDA MARGIN AT 37.4%, UP BY 210 BPS

NOVOZYMES A/S - 2025 OUTLOOK: ORGANIC SALES GROWTH RANGE NARROWED TO 6-8%

INTERIM DIVIDEND OF 2.25 DKK (EUR 0.30) APPROVED FOR H1

Q2 NET SALES EUR 1.02 BILLION

Q2 EBIT EUR 192.5 MILLION

Source text: ID:nGNE4tCL66

Further company coverage: [NSISb.CO]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))